Midwest TXTXT: Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

中西部 TXTXT:扩大循证干预措施以促进艾滋病毒药物依从性

基本信息

项目摘要

PROJECT SUMMARY ABSTRACT In this application, we propose to scale up an Evidence-Based Intervention- TXTXT- by creating a regional hub in the Midwest to coordinate broad dissemination, and to greatly increase reach and impact. We will evaluate the implementation of the EBI scale up via a hybrid type II design to inform the broad dissemination of a region-based implementation model and will elaborate a sustainability plan for TXTXT to inform wide scale dissemination and rapid scale up to additional US regions. Specific Aims: 1. Determine the real-world efficacy of a regional scale up of an EBI- TXTXT- on our primary and secondary outcomes: adherence, viral load suppression, and retention in HIV care, respectively, among poorly adherent racial/ethnic minority YLH, ages 16-35 at 3-and 6-month follow-up. 2. Apply the Consolidated Framework for Implementation Research (CFIR) to describe the implementation process and identify barriers and facilitators needed to be addressed; and measure implementation outcomes of the TXTXT intervention using the RE-AIM framework (Reach, Efficacy, Adoption, Implementation, Maintenance). Dr. Johnson is an ideal candidate for an HIV-focused Implementation Science mentorship award. She is a trained Infectious Disease Epidemiologist with initial certification in Implementation Science approaches and methods (not yet applied). As an early career HIV prevention scientist, she has a breath of experience that stems from community-engaged research which includes basic science, including surveillance and epidemiology as well as intervention development and capacity development initiatives. The next logical step is to gain skills in systems-level implementation science and sustainability planning to inform broad dissemination of evidence-based interventions. This study combines behavioral and social science, implementation science, and information dissemination towards the ultimate goal of public health impact. Medication adherence is a key driver of viral suppression and this regional TXTXT initiative, with a longer-term objective of national dissemination and focused on patients at most risk of virologic failure will directly address local, regional and national goals to End the Epidemic by 2030.
项目摘要摘要 在此应用中,我们建议通过创建区域枢纽来扩展基于证据的干预txtx- 在中西部协调广泛的传播,并大大增加覆盖范围和影响。我们将评估 通过混合II型设计实施EBI规模,以告知广泛的传播 基于区域的实施模型,并将阐明TXTXT的可持续性计划,以告知大规模 传播和快速扩展到其他美国地区。 具体目的: 1。确定eBi-txtxt的区域尺度的现实世界疗效 - 次要结果:分别依从性,病毒负荷抑制和在艾滋病毒护理中保留 在3岁和6个月的随访中,依从性的种族/少数民族少数族裔少数民族,年龄在16-35岁。 2。将合并框架应用于实施研究(CFIR)来描述实施 处理并确定需要解决的障碍和促进者;并衡量实施 使用RE-AIM框架(触及,功效,采用, 实施,维护)。 约翰逊博士是以HIV为重点的实施科学指导奖的理想候选人。她是一个 受过训练的传染病流行病学家,具有实施科学方法的初步认证和 方法(尚未应用)。作为早期职业艾滋病毒预防科学家,她有一段经验 来自社区参与的研究,包括基础科学,包括监视和 流行病学以及干预发展和能力发展计划。下一个逻辑步骤是 获得系统级实施科学和可持续性计划的技能,以告知广泛传播 基于证据的干预措施。这项研究结合了行为和社会科学,实施科学, 和信息传播朝着公共卫生影响的最终目标。药物依从性是关键 病毒抑制和该区域TXTXT倡议的驱动力,其长期目标 传播并关注以病毒衰竭风险的风险的患者,将直接解决地方,区域和 到2030年结束流行病的国家目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Amy Kristen Johnso...的其他基金

RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation
RFA-PS-23-001 - 项目提供:通过实施、传播和评估优化 PrEP
  • 批准号:
    10820208
    10820208
  • 财政年份:
    2023
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Examining Social Ecological and Network Factors to Assess Epidemiological Risk in a Large National Cohort of Cisgender Women
检查社会生态和网络因素以评估全国大型顺性别女性群体的流行病学风险
  • 批准号:
    10543645
    10543645
  • 财政年份:
    2022
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Examining Social Ecological and Network Factors to Assess Epidemiological Risk in a Large National Cohort of Cisgender Women
检查社会生态和网络因素以评估全国大型顺性别女性群体的流行病学风险
  • 批准号:
    10686266
    10686266
  • 财政年份:
    2022
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Implementation and Dissemination of Evidence-Based Interventions to Improve PrEP Care Continuum Outcomes Among Women in Community Health Clinics in the Southern U.S.
实施和传播循证干预措施,以改善美国南部社区健康诊所妇女的 PrEP 护理连续性结果
  • 批准号:
    10472756
    10472756
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Midwest TXTXT: Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
中西部 TXTXT:扩大循证干预措施以促进艾滋病毒药物依从性
  • 批准号:
    10285610
    10285610
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Implementation and Dissemination of Evidence-Based Interventions to Improve PrEP Care Continuum Outcomes Among Women in Community Health Clinics in the Southern U.S.
实施和传播循证干预措施,以改善美国南部社区健康诊所妇女的 PrEP 护理连续性结果
  • 批准号:
    10328104
    10328104
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Midwest TXTXT: Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
中西部 TXTXT:扩大循证干预措施以促进艾滋病毒药物依从性
  • 批准号:
    10395907
    10395907
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Implementation and Dissemination of Evidence-Based Interventions to Improve PrEP Care Continuum Outcomes Among Women in Community Health Clinics in the Southern U.S.
实施和传播循证干预措施,以改善美国南部社区健康诊所妇女的 PrEP 护理连续性结果
  • 批准号:
    10676120
    10676120
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Our stories, our lives, our health: Refining an automated identification of HIV-negative, PrEP-eligible women in the emergency department
我们的故事、我们的生活、我们的健康:完善对急诊科 HIV 阴性且符合 PrEP 资格的女性的自动识别
  • 批准号:
    10021719
    10021719
  • 财政年份:
    2019
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Our stories, our lives, our health: Refining an automated identification of HIV-negative, PrEP-eligible women in the emergency department
我们的故事、我们的生活、我们的健康:完善对急诊科 HIV 阴性且符合 PrEP 资格的女性的自动识别
  • 批准号:
    9927458
    9927458
  • 财政年份:
    2019
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:

相似海外基金

Midwest TXTXT: Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
中西部 TXTXT:扩大循证干预措施以促进艾滋病毒药物依从性
  • 批准号:
    10285610
    10285610
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别:
Midwest TXTXT: Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
中西部 TXTXT:扩大循证干预措施以促进艾滋病毒药物依从性
  • 批准号:
    10395907
    10395907
  • 财政年份:
    2021
  • 资助金额:
    $ 35万
    $ 35万
  • 项目类别: